Ikena Oncology, Inc. ( IKNA) - Key Metrics
Stock symbol IKNA is outdated, potentially delisted? Maybe it is available on other exchange?
IKNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$0.21 | -$0.19 | -$0.19 |
| 2024Q2 | ? | -$0.28 | -$0.26 | -$0.26 |
| 2024Q1 | ? | -$0.33 | -$0.38 | -$0.38 |
| 2023Q4 | $0.01 | -$0.41 | -$0.46 | -$0.46 |
| 2023Q3 | $0.03 | -$0.40 | -$0.46 | -$0.46 |
IKNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -2.04 |
| 2024Q2 | ? | -1.45 |
| 2024Q1 | ? | -1.04 |
| 2023Q4 | ? | -1.21 |
| 2023Q3 | ? | -2.71 |
IKNA
Price: $17.16
52 week price:
Earnings Per Share: -7.68 USD
P/E Ratio: -2.23
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 7489
Market Capitalization: 718.8 million